Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.43+0.12 (+3.63%)
Close on Nov 18, 2026Market cap $31.84MP/E –Yield –
Exozymes revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2023 it was $70.07K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $70.07K | – |
See a number that looks wrong?